Star Imaging And Path Lab Share Price Today | Stock Price & Star Imaging And Path Lab Share Screener
Track the current Star Imaging And Path Lab share price and stock price live with TickJournal's free stock screener. Check STARIMAGIN annual price range for the annual price range and momentum. Use the Star Imaging And Path Lab stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Star Imaging And Path Lab opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Star Imaging And Path Lab Share Price Chart
Track the current stock price of Star Imaging And Path Lab with an interactive chart. Analyse STARIMAGIN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Star Imaging And Path Lab stock quote in one place.
Star Imaging And Path Lab Company Profile - Fundamental Screener
Screen Star Imaging And Path Lab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for STARIMAGIN shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, and it trades under ISIN INE0YG001013.
Company Details
Classification
Identifiers and Leadership
Star Imaging And Path Lab Balance Sheet Screener
Screen STARIMAGIN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹154, up from ₹98 in 2025.
Latest statistics put total assets at ₹154 and shareholder funds at ₹116, with a leverage ratio of 0.33.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
Assets |
|||||
| Total Assets | 154 | 98 | 82 | 61 | 58 |
| Current Assets | 115 | 67 | 53 | 26 | 32 |
| Fixed Assets | 25 | 21 | 22 | 19 | 15 |
Liabilities |
|||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 9 | 17 | 18 | 16 | 19 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||
| Total Equity | 116 | 47 | 31 | 19 | 18 |
| Share Capital | 17 | 14 | 2 | 2 | 2 |
| Reserves & Surplus | 99 | 34 | 30 | 17 | 17 |
Star Imaging And Path Lab Income Statement Screener - Profit & Revenue Analysis
Screen Star Imaging And Path Lab income statement and profit fundamentals. Analyze STARIMAGIN quarterly results. Star Imaging And Path Lab reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹90 and net profit of ₹19.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||
| Revenue | 0 | 90 | 84 | 80 | 59 | 69 |
| Expenses | 0 | 55 | 55 | 56 | 53 | 54 |
Operating Costs and Margins | ||||||
| EBITDA | 0 | 34 | 29 | 24 | 6 | 15 |
| Operating Profit % | 0.00% | 37.00% | 34.00% | 29.00% | 10.00% | 21.00% |
| Depreciation | 0 | 6 | 5 | 5 | 3 | 4 |
| Interest | 0 | 2 | 3 | 2 | 2 | 2 |
Profit and Earnings | ||||||
| Profit Before Tax | 0 | 26 | 21 | 16 | 1 | 9 |
| Tax | 0 | 7 | 6 | 4 | 0 | 3 |
| Net Profit | 0 | 19 | 16 | 13 | 1 | 6 |
| EPS | 0.00 | 11.05 | 11.80 | 82.78 | 3.89 | 41.95 |
Star Imaging And Path Lab Cash Flow Screener - Liquidity Fundamentals
Screen STARIMAGIN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹23, and net cash flow was an inflow of ₹46.
Over the same period, investing activities used ₹13 and financing activities provided ₹36.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|
Cash from Operations and Investing | |||||
| Operating Activities | 23 | -3 | 18 | 5 | 14 |
| Investing Activities | -13 | -7 | -7 | -7 | -4 |
Financing and Net Cash | |||||
| Financing Activities | 36 | 0 | 2 | -5 | -7 |
| Net Cash Flow | 46 | -10 | 13 | -7 | 3 |
Star Imaging And Path Lab Shareholding Pattern Screener
See Star Imaging And Path Lab shareholding pattern with promoter, FII, and DII holdings. Check Star Imaging And Path Lab promoter holding and ownership changes for STARIMAGIN on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 71.92%, foreign institutions 0.61%, domestic institutions 6.14% and the public 16.17%, spread across 773 shareholders.
The shareholder count was 773 in 2026-Mar, compared with 7 in 2025-Mar.
| Item | 2026-Mar | 2025-Mar | 2025-Aug | 2025-Sept |
|---|---|---|---|---|
Promoter Holding | ||||
| Promoter Holding | 71.92% | 100.00% | 71.92% | 71.92% |
Institutional Investors | ||||
| FII Holding | 0.61% | 0.00% | 1.18% | 1.37% |
| DII Holding | 6.14% | 0.00% | 11.44% | 9.33% |
Government, Public and Others | ||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 16.17% | 0.00% | 11.01% | 12.30% |
| Other Holding | 5.16% | 0.00% | 4.46% | 5.08% |
| Shareholder Count | 773 | 7 | 7 | 779 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Star Imaging And Path Lab. Star Imaging And Path Lab dividend yield can be compared with peers and other stocks in the market.
Star Imaging And Path Lab Stock Index Membership - Nifty & Sensex
See which indices include Star Imaging And Path Lab stock. Check STARIMAGIN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Star Imaging And Path Lab Market Events Screener - Corporate Actions
Get Star Imaging And Path Lab corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Star Imaging And Path Lab stock events that may affect STARIMAGIN share price, along with derivatives, futures and options activity and sector gainers.
3 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.
It is followed by Quarterly Result Announcement dated May 22, 2026 and Quarterly Result Announcement dated November 13, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | -12.19% |
| 2026-05-22 | 2026-05-22 | Quarterly Result Announcement | NA | -1.26% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -4.33% |
Star Imaging And Path Lab Competitors Screener - Peer Stocks Comparison
Screen STARIMAGIN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 32,696 | 59.65 | 2,864 | 12.11% | 510 | 58.55 |
| Vijaya Diagnostic Centre | 15,177 | 82.40 | 835 | 19.34% | 173 | 47.24 |
| Metropolis Healthcare | 11,658 | 58.51 | 1,671 | 24.15% | 191 | 40.73 |
| Thyrocare Technologies | 8,708 | 49.67 | 846 | 20.48% | 163 | 40.51 |
| Nephrocare Health Services | 6,657 | 79.69 | 1,023 | 32.93% | 77 | 35.51 |
| Suraksha Diagnostic | 1,849 | 51.63 | 314 | 22.55% | 31 | 65.77 |
| Krsnaa Diagnostics | 1,796 | 17.83 | 816 | 9.90% | 101 | 50.95 |
| 3B BlackBio DX | 1,393 | 24.11 | 142 | 27.17% | 61 | 68.55 |
| One Global Service Provider | 1,044 | 14.38 | 499 | 237.48% | 70 | 45.89 |
| Health X Platform | 907 | -34.21 | 1,319 | 12.68% | -3 | 37.93 |
Star Imaging And Path Lab Company Announcements - News & Reports Screener
Screen STARIMAGIN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated October 4, 2026 and October 2, 2026.
| Date | Update | Actions |
|---|---|---|
| Shareholder Meeting / Postal Ballot-Outcome of AGM | - | |
| 2026-10-04 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Commencement Of Commercial Operations Of CT Scan Facility At Faridabad Haryana | - |
| 2026-10-02 | Closure of Trading Window | - |
| 2026-09-04 | Reg. 34 (1) Annual Report. | - |
| 2026-09-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-01 | Web-Link To Access The Annual Report-2025-26 | - |
| 2026-09-01 | Notice Of 22Nd Annual General Meeting (AGM) Of The Company For The Financial Year 2025-26 | - |
| 2026-09-01 | Reg. 34 (1) Annual Report. | - |
| 2026-08-28 | Outcome Of The Board Meeting Held On Friday August 28 2026 | - |
| 2026-08-28 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday August 28 2026 | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-08 | Intimation Under Regulation 30 - Upgradation Of Tilak Nagar Diagnostic Centre With Toshiba Aquilion ONE 1184 Slice/Second CT Scanner | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-22 | Outcome Of The Board Meeting Held Today I.E. Friday 22 May 2026 | - |
| 2026-05-22 | Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Friday 22 May 2026 | - |
| 2026-05-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-15 | Board Meeting Intimation for To Consider And Approve Audited (Standalone And Consolidated) Financial Results Of The Company For The Half And Financial Year Ended March 31 2026. | - |
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 1.16. Market capitalisation stands at ₹131.10 Cr. The company operates in the Healthcare Services sector, in the Healthcare Service Provider industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 5, 2026. This page covers 5 balance sheet periods, 6 income statement periods, 5 cash flow years and 4 shareholding periods. Information is provided for research and is not investment advice.